|Articles|January 18, 2002
CDER Drug Information, Updated 12/27/01
Author(s)BioPharm International Editors
New and Generic Drug Approvals [Includes Drug Label and Approval Letter] (Updated 12/27/2001)
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
2
EU Clears Subcutaneous Biologic for Lupus, Advancing Patient-Controlled Delivery
3
Charles River Incubator Cohort to Accelerate CGT Development
4
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
5
